ESRP2-NF2-YAP/TAZ轴失调促进非酒精性脂肪性肝病肝胆癌发生
该研究探讨非酒精性脂肪性肝病(NAFLD)中慢性炎症促进肝胆癌(HBC)的机制。利用小鼠NAFLD模型、患者肝活检、肝癌登记数据及细胞系研究,证实炎症相关ESRP2-NF2-YAP/TAZ轴失调促进HBC发生:慢性炎症抑制ESRP2表达,导致NF2失活,进而持续激活YAP/TAZ驱动肝细胞增殖和去分化。
要点
- 慢性炎症抑制肝细胞ESRP2表达,激活YAP/TAZ促癌。
- ESRP2直接靶向并激活抑癌基因NF2。
- NF2功能丧失导致YAP/TAZ持续活化。
核心结论
- 慢性炎症通过抑制ESRP2表达、下调NF2功能,持续激活YAP/TAZ,促进NAFLD相关肝胆癌发生。
研究设计与样本
- 研究采用小鼠NAFLD模型、NAFLD患者肝活检、人类肝癌登记数据及肝癌细胞系研究。
主要发现
- 慢性炎症抑制肝细胞ESRP2(一种RNA剪接因子)表达,ESRP2直接靶向并激活NF2。
- NF2功能丧失导致YAP/TAZ持续活化,驱动肝细胞增殖和去分化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD), the hepatic correlate of the metabolic syndrome, is a major risk factor for hepatobiliary cancer (HBC). Although chronic inflammation is thought to be the root cause of all these diseases, the mechanism whereby it promotes HBC in NAFLD remains poorly understood. Herein, we aim to evaluate the hypothesis that inflammation-related dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes HB carcinogenesis. METHODS: We use murine NAFLD models, liver biopsies from patients with NAFLD, human liver cancer registry data, and studies in liver cancer cell lines. RESULTS: Our results confirm the hypothesis that inflammation-related dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes HB carcinogenesis, supporting a model whereby chronic inflammation suppresses hepatocyte expression of ESRP2, an RNA splicing factor that directly targets and activates NF2, a tumor suppressor that is necessary to constrain YAP/TAZ activation. The resultant loss of NF2 function permits sustained YAP/TAZ activity that drives hepatocyte proliferation and de-differentiation. CONCLUSION: Herein, we report on a novel mechanism by which chronic inflammation leads to sustained activation of YAP/TAZ activity; this imposes a selection pressure that favors liver cells with mutations enabling survival during chronic oncogenic stress. LAY SUMMARY: Non-alcoholic fatty liver disease (NAFLD) increases the risk of hepatobiliary carcinogenesis. However, the underlying mechanism remains unknown. Our study demonstrates that chronic inflammation suppresses hepatocyte expression of ESRP2, an adult RNA splicing factor that activates NF2. Thus, inactive (fetal) NF2 loses the ability to activate Hippo kinases, leading to the increased activity of downstream YAP/TAZ and promoting hepatobiliary carcinogenesis in chronically injured livers.
引用
- Hyun J, Al Abo M, Dutta RK, et al. Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease. J Hepatol. 2021. PMID: 33964370. doi:10.1016/j.jhep.2021.04.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。